查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1701295

生物共轭市场规模、份额、趋势分析报告（按产品/服务、方法、生物分子类型、应用、最终用途、地区、细分预测），2025 年至 2030 年

Bioconjugation Market Size, Share & Trends Analysis Report By Product & Services (Consumables, Instruments, Services), By Technique, By Biomolecule Type, By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

生物共轭市场的成长与趋势：

根据Grand View Research, Inc.的最新报告，全球生物共轭市场规模预计到2030年将达到96.7亿美元，2025年至2030年期间的复合年增长率为9.54%。

生物偶联产业的发展受到标靶治疗需求的不断增长以及肿瘤学和其他治疗领域对抗体药物复合体(ADC) 的日益广泛应用的推动。精准医疗和位特异性生物结合技术的进步正在提高药物疗效并推动市场扩张。生物製药研发投入的不断增加，正在加速生技药品、蛋白质结合和核酸治疗方法的创新。

此外，诊断、生医材料和药物传输系统等领域的应用不断扩大也推动了这一增长，尤其是随着生物感测器和成像剂的采用日益增加。生物共轭合约研究（CRO）和契约製造（CMO）服务的激增进一步推动了市场的发展。此外，监管支援、策略性产业合作以及点击化学和连接技术的技术进步是推动生物共轭产业向前发展的关键因素。

在 COVID-19 大流行期间，对生物结合技术的需求激增，尤其是在疫苗开发和快速诊断领域。生物共轭在增强抗原稳定性和免疫反应以及提高疫苗（例如基于 mRNA 的製剂）的功效方面发挥关键作用。此外，它们广泛用于诊断检测，可以透过生物感测器和免疫测量更快、更准确地检测病毒。对大规模生产的迫切需求导致对 CRO 和 CMO 的外包增加，加速了研发和製造。这些因素凸显了生物结合在应对疫情和疫苗创新中的重要角色。

此外，精准医疗和生技药品的进步推动了对生物共轭技术的需求，从而实现了有针对性的药物传输并提高了治疗效果。抗体药物复合体(ADC)、蛋白质疗法和基因疗法的兴起推动了对精确位点特异性偶联和改进的连接体化学的需求。生物共轭在个人化治疗中也发挥关键作用，可确保更高的特异性并减少副作用。随着生物製药研究和开发的不断扩大，生物共轭技术在药物开发、诊断和生物材料中的应用不断增长，塑造着现代医学的未来。

然而，由于原料昂贵、设备专用、製造製程复杂，生物共轭药物（如抗体-药物偶联物 (ADC) 和胜肽-药物偶联物 (PDC)）的开发成本较高。生产稳定有效的生物共轭物需要先进的连接技术、位点特异性的共轭方法和严格的品管，这进一步增加了成本。此外，高昂的研发成本和漫长的药品核准时间为製药和生技公司带来了巨大的财务风险。监管障碍、大规模临床试验和可扩展性挑战也使得生物结合药物开发成为一个资本密集且耗时的过程，限制了小型公司和新兴企业的进入。

生物共轭市场报告重点

  • 由于对生物结合过程所必需的试剂、连接剂和标记试剂套件的需求量很大，耗材部门在 2024 年占据了市场最大收入份额，为 45.45%。研发活动的活性化和抗体药物复合体（ADC）的日益普及进一步促进了该领域的成长。另一方面，预计服务业在预测期内将以最快的复合年增长率成长。
  • 基于技术，化学结合部分在 2024 年占据了最大的市场收益占有率。这是由于其高效率、扩充性以及在抗体药物结合物 (ADC)、蛋白质标记和奈米颗粒功能化中的广泛应用。其既定的通讯协定和与多种生物分子的兼容性进一步增强了它的优越性。另一方面，点击化学领域预计在预测期内将以最快的复合年增长率成长。
  • 根据生物分子类型，抗体部分在 2024 年占据了最大的市场收益占有率，这得益于其在抗体药物复合体(ADC)、标靶治疗和免疫测量中的关键作用。其高特异性、稳定性以及在肿瘤、感染疾病和精准医疗领域的广泛应用进一步增强了其市场优势。另一方面，寡核苷酸部分预计在预测期内以最快的复合年增长率增长。
  • 根据应用，由于抗体药物复合体(ADC)、胜肽药物偶联物 (PDC) 和标靶药物输送系统的采用日益增多，治疗药物领域预计将在 2024 年占据最大的收益占有率。精准医疗、生物製药和癌症治疗的需求不断增长，推动市场的发展。另一方面，诊断领域预计在预测期内将以最快的复合年增长率成长。
  • 根据最终用途，製药和生物技术公司部门在 2024 年占据了最大的市场收益占有率，这得益于研发投入的增加、对标靶治疗药物的需求以及抗体药物复合体(ADC) 和生技药品的开发。合作研究的增加、生物共轭服务的外包以及精准医疗的进步进一步推动了市场主导地位。另一方面，预计预测期内 CRO 和 CMO 部门的复合年增长率将最快。
  • 2024 年，北美占据市场主导地位，收入份额为 43.75%，这得益于强劲的生物製药研发投资、抗体药物复合体(ADC) 的高度采用以及先进的医疗保健基础设施。大型製药和生物技术公司的存在、有利的监管支持以及对精准医疗的不断增长的需求进一步推动了市场的成长。另一方面，预计亚太地区在预测期内的复合年增长率最快。

目录

第一章调查方法与范围

第二章执行摘要

第三章生物共轭市场变数、趋势与范围

  • 市场展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 生物共轭市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析
    • COVID-19影响分析

第四章生物共轭市场：产品和服务估计和趋势分析

  • 产品/服务细分仪表板
  • 全球生物共轭市场产品与服务差异分析
  • 全球生物共轭市场规模和趋势分析（按产品和服务，2018-2030 年）
  • 耗材
    • 试剂和套件
    • 标籤
    • 其他耗材
  • 装置
    • 层析法系统
    • 光谱仪器
    • 质谱仪
    • 流式细胞仪
    • 电泳设备
    • 过滤系统
    • 搅拌机和搅拌机
    • 培养箱
    • 其他设备
  • 服务
    • 自订合成和结合服务
    • 分析和表征服务
    • 扩大生产和製造服务
    • 其他服务

第五章生物共轭市场：生物分子类型估计与趋势分析

  • 生物分子类型细分仪表板
  • 全球生物共轭市场中生物分子类型的变异分析
  • 2018-2030年全球生物共轭市场规模及趋势分析（依生物分子型态）
  • 抗体
  • 蛋白质
  • 胜肽
  • 寡核苷酸
  • 其他生物分子

第六章生物共轭市场：方法论评估与趋势分析

  • 方法论细分仪表板
  • 全球生物共轭市场方法变异分析
  • 全球生物共轭市场规模及趋势分析（依方法，2018-2030）
  • 化学键
  • 酶介导的结合
  • 点击化学
  • 光反应交联
  • 其他方法

第七章生物共轭市场：应用评估与趋势分析

  • 应用程式细分仪表板
  • 全球生物共轭市场应用变迁分析
  • 全球生物共轭市场规模及应用趋势分析（2018-2030）
  • 治疗
    • 抗体药物复合体
    • 蛋白质-药物偶联物
    • 胜肽-药物偶联物
    • 其他治疗用途
  • 研究与开发
  • 诊断

第八章生物共轭市场：最终用途估计与趋势分析

  • 最终用途细分仪表板
  • 全球生物共轭市场最终用途变化分析
  • 全球生物共轭市场规模与趋势分析（依最终用途）（2018-2030）
  • 製药和生物技术公司
  • CRO 和 CMO
  • 学术研究所
  • 医院、临床实验室、诊断实验室

第九章生物共轭市场：按产品/服务、生物分子类型、技术、应用和最终用途的区域估计和趋势分析

  • 2024 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 2018年至2030年市场规模与预测趋势分析：
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第十章 竞争格局

  • 公司/竞争对手分类
  • 战略地图
  • 2024年企业市场分析
  • 公司简介/列表
    • Danaher
    • Thermo Fisher Scientific Inc.
    • Lonza Group
    • Merck KGaA（MilliporeSigma）
    • Sartorius AG
    • Abbvie, Inc.
    • Bio-Rad Laboratories, Inc.
    • Agilent Technologies, Inc.
    • Catalent, Inc.
    • BD
Product Code: GVR-4-68040-537-0

Bioconjugation Market Growth & Trends:

The global bioconjugation market size is anticipated to reach USD 9.67 billion by 2030 and is projected to grow at a CAGR of 9.54% from 2025 to 2030, according to a new report by Grand View Research, Inc. The bioconjugation industry is driven by rising demand for targeted therapeutics and the growing adoption of antibody-drug conjugates (ADCs) in oncology and other treatments. Advancements in precision medicine and site-specific bioconjugation techniques are enhancing drug efficacy driving market expansion. Increasing biopharmaceutical R&D investments are accelerating innovation in biologics, protein conjugation, and nucleic acid-based therapies.

In addition, expanding applications in diagnostics, biomaterials, and drug delivery systems are also fueling growth, particularly with the rising adoption of biosensors and imaging agents. The surge in contract research (CROs) and contract manufacturing (CMOs) services for bioconjugation is further boosting market development. In addition, regulatory support, strategic industry collaborations, and technological advancements in click chemistry and linker technologies are key factors propelling the bioconjugation industry forward.

During the COVID-19 pandemic, the demand for bioconjugation technologies surged, particularly in vaccine development and rapid diagnostics. Bioconjugation played a crucial role in enhancing antigen stability and immune response, improving the efficacy of vaccines such as mRNA-based formulations. In addition, it was widely used in diagnostic assays, enabling faster and more accurate detection of the virus through biosensors and immunoassays. The urgent need for large-scale production led to increased outsourcing to CROs and CMOs, accelerating R&D and manufacturing. These factors underscored the critical role of bioconjugation in pandemic response and vaccine innovation.

Moreover, advancements in precision medicine and biologics are driving the demand for bioconjugation technologies, enabling targeted drug delivery and enhanced therapeutic efficacy. The rise of antibody-drug conjugates (ADCs), protein therapeutics, and gene therapies has increased the need for precise site-specific conjugation and improved linker chemistry. Bioconjugation also plays a key role in personalized treatments, ensuring higher specificity and reduced side effects. As biopharmaceutical R&D expands, the adoption of bioconjugation techniques in drug development, diagnostics, and biomaterials continues to grow, shaping the future of modern medicine.

However, the development of bioconjugated drugs, such as antibody-drug conjugates (ADCs) and peptide-drug conjugates (PDCs), involves high costs due to expensive raw materials, specialized equipment, and complex manufacturing processes. Producing stable and effective bioconjugates requires advanced linker technologies, site-specific conjugation methods, and stringent quality control, further driving up costs. In addition, high R&D expenses and long drug approval timelines pose significant financial risks for pharmaceutical and biotechnology companies. Regulatory hurdles, extensive clinical trials, and scalability challenges add to the burden, making bioconjugation drug development a capital-intensive and time-consuming process, limiting entry for smaller firms and startups.

Bioconjugation Market Report Highlights:

  • The consumables segment led the market with the largest revenue share of 45.45% in 2024, due to the high demand for reagents, linkers, and labeling kits essential for bioconjugation processes. Increasing R&D activities and the growing adoption of antibody-drug conjugates (ADCs) further fueled segment growth. On the other hand, the services segment is expected to grow at the fastest CAGR over the forecast period.
  • Based on technique, the chemical conjugation segment accounted for the largest market revenue share in 2024, due to its high efficiency, scalability, and widespread use in antibody-drug conjugates (ADCs), protein labeling, and nanoparticle functionalization. Its well-established protocols and compatibility with various biomolecules further drove its dominance. On the other hand, the click chemistry segment is expected to grow at the fastest CAGR over the forecast period.
  • Based on biomolecule type, the antibodies segment accounted for the largest market revenue share in 2024, due to their crucial role in antibody-drug conjugates (ADCs), targeted therapeutics, and immunoassays. Their high specificity, stability, and widespread application in oncology, infectious diseases, and precision medicine further drive market dominance. On the other hand, the oligonucleotides segment is expected to grow at the fastest CAGR over the forecast period.
  • Based on application, the therapeutics segment accounted for the largest revenue share in 2024, due to the rising adoption of antibody-drug conjugates (ADCs), peptide-drug conjugates (PDCs), and targeted drug delivery systems. Increasing demand for precision medicine, biologics, and cancer therapies further drives its market leadership. On the other hand, the diagnostics segment is expected to grow at the fastest CAGR over the forecast period.
  • Based on end use, the pharmaceutical & biotechnological companies segment accounted for the largest market revenue share in 2024, due to increasing R&D investments, demand for targeted therapeutics, and the development of antibody-drug conjugates (ADCs) and biologics. Growing collaborations, outsourcing of bioconjugation services, and advancements in precision medicine further fueled market dominance. On the other hand, the CROs & CMOs segment is expected to grow at the fastest CAGR over the forecast period.
  • The North America dominated the market with the largest revenue share of 43.75% in 2024, driven by strong biopharmaceutical R&D investments, high adoption of antibody-drug conjugates (ADCs), and advanced healthcare infrastructure. The presence of leading pharmaceutical & biotechnology companies, favorable regulatory support, and growing demand for precision medicine further fueled market growth. On the other hand, the Asia Pacific region is anticipated to grow at the fastest CAGR over the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Product & Services
    • 1.2.2. Biomolecule Type
    • 1.2.3. Technique
    • 1.2.4. Application
    • 1.2.5. End Use
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Bioconjugation Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising demand for targeted drug delivery
      • 3.2.1.2. Technological innovations in linker chemistry
      • 3.2.1.3. Growing applications in diagnostics
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High development costs
      • 3.2.2.2. Short shelf life of bioconjugated products
      • 3.2.2.3. Alternative drug delivery technologies
  • 3.3. Bioconjugation Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Bioconjugation Market: Product & Services Estimates & Trend Analysis

  • 4.1. Product & Services Segment Dashboard
  • 4.2. Global Bioconjugation Market Product & Services Movement Analysis
  • 4.3. Global Bioconjugation Market Size & Trend Analysis, by Product & Services, 2018 to 2030 (USD Million)
  • 4.4. Consumables
    • 4.4.1. Consumables market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.2. Reagents & Kits
      • 4.4.2.1. Reagents & kits market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.2.2. Linker & Crosslinking Reagents & Kits
        • 4.4.2.2.1. Linker & crosslinking reagents & kits market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.2.3. Labeling Reagents & Kits
        • 4.4.2.3.1. Labeling reagents & kits market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.2.4. Modification Reagents & Kits
        • 4.4.2.4.1. Modification reagents & kits market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.2.5. Other Reagents & Kits
        • 4.4.2.5.1. Other reagents & kits market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.3. Labels
      • 4.4.3.1. Labels market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.3.2. Fluorescent Tags
        • 4.4.3.2.1. Fluorescent tags market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.3.3. Enzymes
        • 4.4.3.3.1. Enzymes market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.3.4. Haptens
        • 4.4.3.4.1. Haptens market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.3.5. Polymers
        • 4.4.3.5.1. Polymers market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.3.6. Bead Coupling
        • 4.4.3.6.1. Bead coupling market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.3.7. Other Labels
        • 4.4.3.7.1. Other labels market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.4. Other Consumables
      • 4.4.4.1. Other consumables market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Instruments
    • 4.5.1. Instruments market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.5.2. Chromatography Systems
      • 4.5.2.1. Chromatography systems market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.5.3. Spectroscopy Instruments
      • 4.5.3.1. Spectroscopy instruments market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.5.4. Mass Spectrometers
      • 4.5.4.1. Mass spectrometers market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.5.5. Flow Cytometers
      • 4.5.5.1. Flow cytometers market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.5.6. Electrophoresis Equipment
      • 4.5.6.1. Electrophoresis equipment market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.5.7. Filtration Systems
      • 4.5.7.1. Filtration systems market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.5.8. Mixers & Shakers
      • 4.5.8.1. Mixers & shakers market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.5.9. Incubators
      • 4.5.9.1. Incubators market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.5.10. Other Instruments
      • 4.5.10.1. Other instruments market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. Services
    • 4.6.1. Services market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.6.2. Custom Synthesis & Conjugation Services
      • 4.6.2.1. Custom synthesis & conjugation services market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.6.3. Analytical & Characterization Services
      • 4.6.3.1. Analytical & characterization services market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.6.4. Scale-up & Manufacturing Services
      • 4.6.4.1. Scale-up & manufacturing services market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.6.5. Other Services
      • 4.6.5.1. Other services market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Bioconjugation Market: Biomolecule Type Estimates & Trend Analysis

  • 5.1. Biomolecule Type Segment Dashboard
  • 5.2. Global Bioconjugation Market Biomolecule Type Movement Analysis
  • 5.3. Global Bioconjugation Market Size & Trend Analysis, by Biomolecule Type, 2018 to 2030 (USD Million)
  • 5.4. Antibodies
    • 5.4.1. Antibodies market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Proteins
    • 5.5.1. Proteins market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Peptides
    • 5.6.1. Peptides market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.7. Oligonucleotides
    • 5.7.1. Oligonucleotides market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.8. Other Biomolecules
    • 5.8.1. Other biomolecules market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Bioconjugation Market: Technique Estimates & Trend Analysis

  • 6.1. Technique Segment Dashboard
  • 6.2. Global Bioconjugation Market Technique Movement Analysis
  • 6.3. Global Bioconjugation Market Size & Trend Analysis, by Technique, 2018 to 2030 (USD Million)
  • 6.4. Chemical Conjugation
    • 6.4.1. Chemical conjugation market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. Enzyme-Mediated Conjugation
    • 6.5.1. Enzyme-mediated conjugation market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.6. Click Chemistry
    • 6.6.1. Click chemistry market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.7. Photoreactive Crosslinking
    • 6.7.1. Photoreactive crosslinking market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.8. Other Techniques
    • 6.8.1. Other techniques market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Bioconjugation Market: Application Estimates & Trend Analysis

  • 7.1. Application Segment Dashboard
  • 7.2. Global Bioconjugation Market Application Movement Analysis
  • 7.3. Global Bioconjugation Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 7.4. Therapeutics
    • 7.4.1. Therapeutics market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.2. Antibody-drug Conjugates
      • 7.4.2.1. Antibody-drug conjugates market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.3. Protein-drug Conjugates
      • 7.4.3.1. Protein-drug conjugates market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.4. Peptide-drug Conjugates
      • 7.4.4.1. Peptide-drug conjugates market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.5. Other Therapeutic Applications
      • 7.4.5.1. Other therapeutic applications market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.5. Research & Development
    • 7.5.1. Research & development market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.6. Diagnostics
    • 7.6.1. Diagnostics market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. Bioconjugation Market: End Use Estimates & Trend Analysis

  • 8.1. End Use Segment Dashboard
  • 8.2. Global Bioconjugation Market End Use Movement Analysis
  • 8.3. Global Bioconjugation Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 8.4. Pharmaceutical & Biotechnology Companies
    • 8.4.1. Pharmaceutical & biotechnology companies market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.5. CROs & CMOs
    • 8.5.1. CROs & CMOs market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.6. Academic & Research Institutes
    • 8.6.1. Academic & research institutes market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.7. Hospitals, Clinical, & Diagnostic Laboratories
    • 8.7.1. Hospitals, clinical, & diagnostic laboratories market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 9. Bioconjugation Market: Regional Estimates & Trend Analysis by Product & Services, Biomolecule Type, Technique, Application, and End Use

  • 9.1. Regional Market Share Analysis, 2024 & 2030
  • 9.2. Regional Market Dashboard
  • 9.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 9.4. North America
    • 9.4.1. North America market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.4.2. U.S.
      • 9.4.2.1. Key country dynamics
      • 9.4.2.2. Regulatory framework
      • 9.4.2.3. Competitive scenario
      • 9.4.2.4. U.S. market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.4.3. Canada
      • 9.4.3.1. Key country dynamics
      • 9.4.3.2. Regulatory framework
      • 9.4.3.3. Competitive scenario
      • 9.4.3.4. Canada market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.4.4. Mexico
      • 9.4.4.1. Key country dynamics
      • 9.4.4.2. Regulatory framework
      • 9.4.4.3. Competitive scenario
      • 9.4.4.4. Mexico market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.5. Europe
    • 9.5.1. Europe market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.5.2. UK
      • 9.5.2.1. Key country dynamics
      • 9.5.2.2. Regulatory framework
      • 9.5.2.3. Competitive scenario
      • 9.5.2.4. UK market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.5.3. Germany
      • 9.5.3.1. Key country dynamics
      • 9.5.3.2. Regulatory framework
      • 9.5.3.3. Competitive scenario
      • 9.5.3.4. Germany market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.5.4. France
      • 9.5.4.1. Key country dynamics
      • 9.5.4.2. Regulatory framework
      • 9.5.4.3. Competitive scenario
      • 9.5.4.4. France market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.5.5. Italy
      • 9.5.5.1. Key country dynamics
      • 9.5.5.2. Regulatory framework
      • 9.5.5.3. Competitive scenario
      • 9.5.5.4. Italy market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.5.6. Spain
      • 9.5.6.1. Key country dynamics
      • 9.5.6.2. Regulatory framework
      • 9.5.6.3. Competitive scenario
      • 9.5.6.4. Spain market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.5.7. Norway
      • 9.5.7.1. Key country dynamics
      • 9.5.7.2. Regulatory framework
      • 9.5.7.3. Competitive scenario
      • 9.5.7.4. Norway market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.5.8. Sweden
      • 9.5.8.1. Key country dynamics
      • 9.5.8.2. Regulatory framework
      • 9.5.8.3. Competitive scenario
      • 9.5.8.4. Sweden market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.5.9. Denmark
      • 9.5.9.1. Key country dynamics
      • 9.5.9.2. Regulatory framework
      • 9.5.9.3. Competitive scenario
      • 9.5.9.4. Denmark market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.6. Asia Pacific
    • 9.6.1. Asia Pacific market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.6.2. Japan
      • 9.6.2.1. Key country dynamics
      • 9.6.2.2. Regulatory framework
      • 9.6.2.3. Competitive scenario
      • 9.6.2.4. Japan market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.6.3. China
      • 9.6.3.1. Key country dynamics
      • 9.6.3.2. Regulatory framework
      • 9.6.3.3. Competitive scenario
      • 9.6.3.4. China market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.6.4. India
      • 9.6.4.1. Key country dynamics
      • 9.6.4.2. Regulatory framework
      • 9.6.4.3. Competitive scenario
      • 9.6.4.4. India market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.6.5. Australia
      • 9.6.5.1. Key country dynamics
      • 9.6.5.2. Regulatory framework
      • 9.6.5.3. Competitive scenario
      • 9.6.5.4. Australia market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.6.6. South Korea
      • 9.6.6.1. Key country dynamics
      • 9.6.6.2. Regulatory framework
      • 9.6.6.3. Competitive scenario
      • 9.6.6.4. South Korea market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.6.7. Thailand
      • 9.6.7.1. Key country dynamics
      • 9.6.7.2. Regulatory framework
      • 9.6.7.3. Competitive scenario
      • 9.6.7.4. Thailand market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.7. Latin America
    • 9.7.1. Latin America market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.7.2. Brazil
      • 9.7.2.1. Key country dynamics
      • 9.7.2.2. Regulatory framework
      • 9.7.2.3. Competitive scenario
      • 9.7.2.4. Brazil market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.7.3. Argentina
      • 9.7.3.1. Key country dynamics
      • 9.7.3.2. Regulatory framework
      • 9.7.3.3. Competitive scenario
      • 9.7.3.4. Argentina market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.8. MEA
    • 9.8.1. MEA market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.8.2. South Africa
      • 9.8.2.1. Key country dynamics
      • 9.8.2.2. Regulatory framework
      • 9.8.2.3. Competitive scenario
      • 9.8.2.4. South Africa market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.8.3. Saudi Arabia
      • 9.8.3.1. Key country dynamics
      • 9.8.3.2. Regulatory framework
      • 9.8.3.3. Competitive scenario
      • 9.8.3.4. Saudi Arabia market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.8.4. UAE
      • 9.8.4.1. Key country dynamics
      • 9.8.4.2. Regulatory framework
      • 9.8.4.3. Competitive scenario
      • 9.8.4.4. UAE market estimates and forecasts, 2018 to 2030 (USD Million)
    • 9.8.5. Kuwait
      • 9.8.5.1. Key country dynamics
      • 9.8.5.2. Regulatory framework
      • 9.8.5.3. Competitive scenario
      • 9.8.5.4. Kuwait market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Company/Competition Categorization
  • 10.2. Strategy Mapping
  • 10.3. Company Market Position Analysis, 2024
  • 10.4. Company Profiles/Listing
    • 10.4.1. Danaher
      • 10.4.1.1. Company overview
      • 10.4.1.2. Financial performance
      • 10.4.1.3. Product benchmarking
      • 10.4.1.4. Strategic initiatives
    • 10.4.2. Thermo Fisher Scientific Inc.
      • 10.4.2.1. Company overview
      • 10.4.2.2. Financial performance
      • 10.4.2.3. Product benchmarking
      • 10.4.2.4. Strategic initiatives
    • 10.4.3. Lonza Group
      • 10.4.3.1. Company overview
      • 10.4.3.2. Financial performance
      • 10.4.3.3. Product benchmarking
      • 10.4.3.4. Strategic initiatives
    • 10.4.4. Merck KGaA (MilliporeSigma)
      • 10.4.4.1. Company overview
      • 10.4.4.2. Financial performance
      • 10.4.4.3. Product benchmarking
      • 10.4.4.4. Strategic initiatives
    • 10.4.5. Sartorius AG
      • 10.4.5.1. Company overview
      • 10.4.5.2. Financial performance
      • 10.4.5.3. Product benchmarking
      • 10.4.5.4. Strategic initiatives
    • 10.4.6. Abbvie, Inc.
      • 10.4.6.1. Company overview
      • 10.4.6.2. Financial performance
      • 10.4.6.3. Product benchmarking
      • 10.4.6.4. Strategic initiatives
    • 10.4.7. Bio-Rad Laboratories, Inc.
      • 10.4.7.1. Company overview
      • 10.4.7.2. Financial performance
      • 10.4.7.3. Product benchmarking
      • 10.4.7.4. Strategic initiatives
    • 10.4.8. Agilent Technologies, Inc.
      • 10.4.8.1. Company overview
      • 10.4.8.2. Financial performance
      • 10.4.8.3. Product benchmarking
      • 10.4.8.4. Strategic initiatives
    • 10.4.9. Catalent, Inc.
      • 10.4.9.1. Company overview
      • 10.4.9.2. Financial performance
      • 10.4.9.3. Product benchmarking
      • 10.4.9.4. Strategic initiatives
    • 10.4.10. BD
      • 10.4.10.1. Company overview
      • 10.4.10.2. Financial performance
      • 10.4.10.3. Product benchmarking
      • 10.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global bioconjugation market, by region, 2018 - 2030 (USD Million)
  • Table 3 Global bioconjugation market, by product & services, 2018 - 2030 (USD Million)
  • Table 4 Global bioconjugation market, by technique, 2018 - 2030 (USD Million)
  • Table 5 Global bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
  • Table 6 Global bioconjugation market, by application, 2018 - 2030 (USD Million)
  • Table 7 Global bioconjugation market, by end use, 2018 - 2030 (USD Million)
  • Table 8 North America bioconjugation market, by country, 2018 - 2030 (USD Million)
  • Table 9 North America bioconjugation market, by product & services, 2018 - 2030 (USD Million)
  • Table 10 North America bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
  • Table 11 North America bioconjugation market, by technique, 2018 - 2030 (USD Million)
  • Table 12 North America bioconjugation market, by application, 2018 - 2030 (USD Million)
  • Table 13 North America bioconjugation market, by end use, 2018 - 2030 (USD Million)
  • Table 14 U.S. bioconjugation market, by product & services, 2018 - 2030 (USD Million)
  • Table 15 U.S. bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
  • Table 16 U.S. bioconjugation market, by technique, 2018 - 2030 (USD Million)
  • Table 17 U.S. bioconjugation market, by application, 2018 - 2030 (USD Million)
  • Table 18 U.S. bioconjugation market, by end use, 2018 - 2030 (USD Million)
  • Table 19 Canada bioconjugation market, by product & services, 2018 - 2030 (USD Million)
  • Table 20 Canada bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
  • Table 21 Canada bioconjugation market, by technique, 2018 - 2030 (USD Million)
  • Table 22 Canada bioconjugation market, by application, 2018 - 2030 (USD Million)
  • Table 23 Canada bioconjugation market, by end use, 2018 - 2030 (USD Million)
  • Table 24 Mexico bioconjugation market, by product & services, 2018 - 2030 (USD Million)
  • Table 25 Mexico bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
  • Table 26 Mexico bioconjugation market, by technique, 2018 - 2030 (USD Million)
  • Table 27 Mexico bioconjugation market, by application, 2018 - 2030 (USD Million)
  • Table 28 Mexico bioconjugation market, by end use, 2018 - 2030 (USD Million)
  • Table 29 Europe bioconjugation market, by country, 2018 - 2030 (USD Million)
  • Table 30 Europe bioconjugation market, by product & services, 2018 - 2030 (USD Million)
  • Table 31 Europe bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
  • Table 32 Europe bioconjugation market, by technique, 2018 - 2030 (USD Million)
  • Table 33 Europe bioconjugation market, by application, 2018 - 2030 (USD Million)
  • Table 34 Europe bioconjugation market, by end use, 2018 - 2030 (USD Million)
  • Table 35 Germany bioconjugation market, by product & services, 2018 - 2030 (USD Million)
  • Table 36 Germany bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
  • Table 37 Germany bioconjugation market, by technique, 2018 - 2030 (USD Million)
  • Table 38 Germany bioconjugation market, by application, 2018 - 2030 (USD Million)
  • Table 39 Germany bioconjugation market, by end use, 2018 - 2030 (USD Million)
  • Table 40 UK bioconjugation market, by product & services, 2018 - 2030 (USD Million)
  • Table 41 UK bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
  • Table 42 UK bioconjugation market, by technique, 2018 - 2030 (USD Million)
  • Table 43 UK bioconjugation market, by application, 2018 - 2030 (USD Million)
  • Table 44 UK bioconjugation market, by end use, 2018 - 2030 (USD Million)
  • Table 45 France bioconjugation market, by product & services, 2018 - 2030 (USD Million)
  • Table 46 France bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
  • Table 47 France bioconjugation market, by technique, 2018 - 2030 (USD Million)
  • Table 48 France bioconjugation market, by application, 2018 - 2030 (USD Million)
  • Table 49 France bioconjugation market, by end use, 2018 - 2030 (USD Million)
  • Table 50 Italy bioconjugation market, by product & services, 2018 - 2030 (USD Million)
  • Table 51 Italy bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
  • Table 52 Italy bioconjugation market, by technique, 2018 - 2030 (USD Million)
  • Table 53 Italy bioconjugation market, by application, 2018 - 2030 (USD Million)
  • Table 54 Italy bioconjugation market, by end use, 2018 - 2030 (USD Million)
  • Table 55 Spain bioconjugation market, by product & services, 2018 - 2030 (USD Million)
  • Table 56 Spain bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
  • Table 57 Spain bioconjugation market, by technique, 2018 - 2030 (USD Million)
  • Table 58 Spain bioconjugation market, by application, 2018 - 2030 (USD Million)
  • Table 59 Spain bioconjugation market, by end use, 2018 - 2030 (USD Million)
  • Table 60 Denmark bioconjugation market, by product & services, 2018 - 2030 (USD Million)
  • Table 61 Denmark bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
  • Table 62 Denmark bioconjugation market, by technique, 2018 - 2030 (USD Million)
  • Table 63 Denmark bioconjugation market, by application, 2018 - 2030 (USD Million)
  • Table 64 Denmark bioconjugation market, by end use, 2018 - 2030 (USD Million)
  • Table 65 Sweden bioconjugation market, by product & services, 2018 - 2030 (USD Million)
  • Table 66 Sweden bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
  • Table 67 Sweden bioconjugation market, by technique, 2018 - 2030 (USD Million
  • Table 68 Sweden bioconjugation market, by application, 2018 - 2030 (USD Million
  • Table 69 Sweden bioconjugation market, by end use, 2018 - 2030 (USD Million
  • Table 70 Norway bioconjugation market, by product & services, 2018 - 2030 (USD Million)
  • Table 71 Norway bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
  • Table 72 Norway bioconjugation market, by technique, 2018 - 2030 (USD Million
  • Table 73 Norway bioconjugation market, by application, 2018 - 2030 (USD Million
  • Table 74 Norway bioconjugation market, by end use, 2018 - 2030 (USD Million
  • Table 75 Asia Pacific bioconjugation market, by country, 2018 - 2030 (USD Million)
  • Table 76 Asia Pacific bioconjugation market, by product & services, 2018 - 2030 (USD Million)
  • Table 77 Asia Pacific bioconjugation market, by technique, 2018 - 2030 (USD Million
  • Table 78 Asia Pacific bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
  • Table 79 Asia Pacific bioconjugation market, by application, 2018 - 2030 (USD Million
  • Table 80 Asia Pacific bioconjugation market, by end use, 2018 - 2030 (USD Million
  • Table 81 China bioconjugation market, by product & services, 2018 - 2030 (USD Million)
  • Table 82 China bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
  • Table 83 China bioconjugation market, by technique, 2018 - 2030 (USD Million)
  • Table 84 China bioconjugation market, by application, 2018 - 2030 (USD Million)
  • Table 85 China bioconjugation market, by end use, 2018 - 2030 (USD Million)
  • Table 86 Japan bioconjugation market, by product & services, 2018 - 2030 (USD Million)
  • Table 87 Japan bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
  • Table 88 Japan bioconjugation market, by technique, 2018 - 2030 (USD Million)
  • Table 89 Japan bioconjugation market, by application, 2018 - 2030 (USD Million)
  • Table 90 Japan bioconjugation market, by end use, 2018 - 2030 (USD Million)
  • Table 91 India bioconjugation market, by product & services, 2018 - 2030 (USD Million)
  • Table 92 India bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
  • Table 93 India bioconjugation market, by technique, 2018 - 2030 (USD Million)
  • Table 94 India bioconjugation market, by application, 2018 - 2030 (USD Million)
  • Table 95 India bioconjugation market, by end use, 2018 - 2030 (USD Million)
  • Table 96 South Korea bioconjugation market, by product & services, 2018 - 2030 (USD Million)
  • Table 97 South Korea bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
  • Table 98 South Korea bioconjugation market, by technique, 2018 - 2030 (USD Million)
  • Table 99 South Korea bioconjugation market, by application, 2018 - 2030 (USD Million)
  • Table 100 South Korea bioconjugation market, by end use, 2018 - 2030 (USD Million)
  • Table 101 Australia bioconjugation market, by product & services, 2018 - 2030 (USD Million)
  • Table 102 Australia bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
  • Table 103 Australia bioconjugation market, by technique, 2018 - 2030 (USD Million)
  • Table 104 Australia bioconjugation market, by application, 2018 - 2030 (USD Million)
  • Table 105 Australia bioconjugation market, by end use, 2018 - 2030 (USD Million)
  • Table 106 Thailand bioconjugation market, by product & services, 2018 - 2030 (USD Million)
  • Table 107 Thailand bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
  • Table 108 Thailand bioconjugation market, by technique, 2018 - 2030 (USD Million)
  • Table 109 Thailand bioconjugation market, by application, 2018 - 2030 (USD Million)
  • Table 110 Thailand bioconjugation market, by end use, 2018 - 2030 (USD Million)
  • Table 111 Latin America bioconjugation market, by country, 2018 - 2030 (USD Million)
  • Table 112 Latin America bioconjugation market, by product & services, 2018 - 2030 (USD Million)
  • Table 113 Latin America bioconjugation market, by technique, 2018 - 2030 (USD Million)
  • Table 114 Latin America bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
  • Table 115 Latin America bioconjugation market, by application, 2018 - 2030 (USD Million)
  • Table 116 Latin America bioconjugation market, by end use, 2018 - 2030 (USD Million)
  • Table 117 Brazil bioconjugation market, by product & services, 2018 - 2030 (USD Million)
  • Table 118 Brazil bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
  • Table 119 Brazil bioconjugation market, by technique, 2018 - 2030 (USD Million)
  • Table 120 Brazil bioconjugation market, by application, 2018 - 2030 (USD Million)
  • Table 121 Brazil bioconjugation market, by end use, 2018 - 2030 (USD Million)
  • Table 122 Argentina bioconjugation market, by product & services, 2018 - 2030 (USD Million)
  • Table 123 Argentina bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
  • Table 124 Argentina bioconjugation market, by technique, 2018 - 2030 (USD Million)
  • Table 125 Argentina bioconjugation market, by application, 2018 - 2030 (USD Million)
  • Table 126 Argentina bioconjugation market, by end use, 2018 - 2030 (USD Million)
  • Table 127 MEA bioconjugation market, by country, 2018 - 2030 (USD Million)
  • Table 128 MEA bioconjugation market, by product & services, 2018 - 2030 (USD Million)
  • Table 129 MEA bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
  • Table 130 MEA bioconjugation market, by technique, 2018 - 2030 (USD Million)
  • Table 131 MEA bioconjugation market, by application, 2018 - 2030 (USD Million)
  • Table 132 MEA bioconjugation market, by end use, 2018 - 2030 (USD Million)
  • Table 133 South Africa bioconjugation market, by product & services, 2018 - 2030 (USD Million)
  • Table 134 South Africa bioconjugation market, by technique, 2018 - 2030 (USD Million)
  • Table 135 South Africa bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
  • Table 136 South Africa bioconjugation market, by application, 2018 - 2030 (USD Million)
  • Table 137 South Africa bioconjugation market, by end use, 2018 - 2030 (USD Million)
  • Table 138 Saudi Arabia bioconjugation market, by product & services, 2018 - 2030 (USD Million)
  • Table 139 Saudi Arabia bioconjugation market, by technique, 2018 - 2030 (USD Million)
  • Table 140 Saudi Arabia bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
  • Table 141 Saudi Arabia bioconjugation market, by application, 2018 - 2030 (USD Million)
  • Table 142 Saudi Arabia bioconjugation market, by end use, 2018 - 2030 (USD Million)
  • Table 143 UAE bioconjugation market, by product & services, 2018 - 2030 (USD Million)
  • Table 144 UAE bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
  • Table 145 UAE bioconjugation market, by technique, 2018 - 2030 (USD Million)
  • Table 146 UAE bioconjugation market, by application, 2018 - 2030 (USD Million)
  • Table 147 UAE bioconjugation market, by end use, 2018 - 2030 (USD Million)
  • Table 148 Kuwait bioconjugation market, by product & services, 2018 - 2030 (USD Million)
  • Table 149 Kuwait bioconjugation market, by biomolecule type, 2018 - 2030 (USD Million)
  • Table 150 Kuwait bioconjugation market, by technique, 2018 - 2030 (USD Million)
  • Table 151 Kuwait bioconjugation market, by application, 2018 - 2030 (USD Million)
  • Table 152 Kuwait bioconjugation market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market formulation & validation
  • Fig. 4 Bioconjugation market: Market outlook
  • Fig. 5 Bioconjugation market: Segment outlook
  • Fig. 6 Bioconjugation market: Competitive landscape outlook
  • Fig. 7 Parent market outlook
  • Fig. 8 Bioconjugation market driver impact
  • Fig. 9 Bioconjugation market restraint impact
  • Fig. 10 Bioconjugation market: Product & services outlook and key takeaways
  • Fig. 11 Bioconjugation market: Product & services movement analysis
  • Fig. 12 Consumables market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 13 Kits & reagents market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 14 Linker & crosslinking reagents & kits market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 15 Labeling reagents & kits market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 16 Modification reagents & kits market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 17 Other reagents & kits market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 18 Labels market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Fluorescent tags market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Enzymes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Haptens market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Polymers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Bead coupling market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Other labels market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Other consumables market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Chromatography systems market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Spectroscopy instruments market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Mass spectrometers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Flow cytometers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Electrophoresis equipment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Filtration systems market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Mixers & shakers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Incubators market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Other instruments market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Custom synthesis & conjugation services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Analytical & characterization services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Scale-up & manufacturing services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Other services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Bioconjugation market: Biomolecule type outlook and key takeaways
  • Fig. 42 Bioconjugation market: Biomolecule type movement analysis
  • Fig. 43 Antibodies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Proteins market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 Peptides market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Oligonucleotides market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Other biomolecules market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Bioconjugation market: Technique outlook and key takeaways
  • Fig. 49 Bioconjugation market: Technique movement analysis
  • Fig. 50 Chemical conjugation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Enzyme-mediated conjugation market estimates and forecast, 2018 - 2030 (USD Million
  • Fig. 52 Click chemistry market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 Photoreactive crosslinking market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Other techniques market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 Bioconjugation market: Application outlook and key takeaways
  • Fig. 56 Bioconjugation market: Application movement analysis
  • Fig. 57 Therapeutics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 58 Antibody-drug conjugates market estimates and forecast, 2018 - 2030 (USD Million
  • Fig. 59 Protein-drug conjugates market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 60 Peptide-drug conjugates market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 61 Other therapeutic applications market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 Research & Development market estimates and forecast, 2018 - 2030 (USD Million
  • Fig. 63 Diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 64 Bioconjugation market: End use outlook and key takeaways
  • Fig. 65 Bioconjugation market: End use movement analysis
  • Fig. 66 Pharmaceutical & biotechnology companies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 CROs & CMOs market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 68 Academic & research institutes market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 69 Hospitals, clinical, & diagnostic laboratories market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 70 Global bioconjugation market: Regional outlook and key takeaways
  • Fig. 71 Global bioconjugation market: Regional movement analysis
  • Fig. 72 North America bioconjugation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 US bioconjugation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Canada bioconjugation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 Mexico bioconjugation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Europe bioconjugation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 UK bioconjugation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 Germany bioconjugation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 France bioconjugation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 Italy bioconjugation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 81 Spain bioconjugation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 Denmark bioconjugation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 83 Sweden bioconjugation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 84 Norway bioconjugation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 85 Asia Pacific bioconjugation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 86 China bioconjugation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 87 Japan bioconjugation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 88 India bioconjugation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 89 Thailand bioconjugation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 90 South Korea bioconjugation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 91 Australia bioconjugation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 92 Latin America bioconjugation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 93 Brazil bioconjugation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 94 Argentina bioconjugation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 95 Middle East and Africa bioconjugation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 96 South Africa bioconjugation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 97 Saudi Arabia bioconjugation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 98 UAE bioconjugation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 99 Kuwait bioconjugation market estimates and forecasts, 2018 - 2030 (USD Million)